logo

NSRX

Nasus Pharma·AMEX
--
--(--)
--
--(--)

Key Stats

0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000

About NSRX

Nasus Pharma Ltd.

A clinical-stage specialty pharmaceutical company primarily focused on developing intranasal drugs for treating emergency medical conditions

Pharmaceutical
--
08/13/2025
American Stock Exchange
1
12-31
Common stock
Yigal Alon 65 Tel Aviv Israel 6744317
--
Nasus Pharma Ltd., an Israeli company, was incorporated in Israel in May 2019. They are a clinical stage specialty pharmaceutical company focused on the development of intranasal medicines for the treatment of emergency medical conditions. They are developing a unique PBI technology with a dedicated product portfolio to address acute medical conditions and public health threats.

Company Financials

Forecast

Wall Street Opinions

Price Target

Volume Profile

Trade Flow Insight

Seasonals

Community Forum

Loading...

Related News

No articles available

Related Symbols

You can ask Aime

No Data